Bio-Thera Solutions Files IND for Phase 1 Clinical Trial with BAT8003 (Trop2-ADC) as Treatment for Trop2 Positive Cancers

(Source: PipelineReview.com) Subject to NMPA acceptance, Bio-Thera Solutions plans to initiate the Phase I … clinical trials and has applied for marketing authorization for one candidate.